skip to main content skip to main navigation
Summer 2013 / Issue 71 (originally published by Booz & Company)

s+b Trend Watch: Big Pharma’s Potential in Emerging Markets

Emerging economies are becoming the industry's best hope for growth.

Pharmaceutical markets in developed countries may still be quite sizable, but in 2011–12 they were mostly stagnant—or worse. Not so in emerging economies, which are becoming the industry’s best hope for growth.


Get s+b's award-winning newsletter delivered to your inbox. Sign up No, thanks
Illustration of flying birds delivering information

Get the strategy+business newsletter delivered to your inbox